Stay updated on Pembrolizumab in Endometrial Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in Endometrial Cancer Clinical Trial page.

Latest updates to the Pembrolizumab in Endometrial Cancer Clinical Trial page
- Check4 days agoChange DetectedThe page footer revision tag was updated from v3.6.3 to v3.6.4. This indicates a small maintenance release and does not change page content or functionality.SummaryDifference0.1%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check26 days agoChange DetectedThe page's revision tag was updated from v3.6.2 to v3.6.3. This indicates a minor platform update and does not affect study content or presented results.SummaryDifference0.1%

- Check33 days agoChange DetectedThe page now shows Revision: v3.6.2, replacing Revision: v3.6.0. This reflects an update to the page's version tag rather than changes to study content or functionality.SummaryDifference0.1%

- Check47 days agoChange DetectedThe page now displays 'No longer looking for participants', indicating that enrollment is closed for this study. Other updates include adding navigation/help sections such as 'How to Read a Study Record', 'Common Questions', and 'How to Join a Study', and updating the revision label to v3.6.0, along with minor formatting tweaks to headers.SummaryDifference0.5%

- Check54 days agoChange DetectedThe page now displays Revision: v3.5.5, replacing the previous Revision: v3.5.4, indicating a minor site release. There are no changes to the study details or user-facing content evident in this update.SummaryDifference0.1%

- Check76 days agoChange DetectedA platform revision was updated from v3.5.3 to v3.5.4, indicating an underlying update to the site. It does not modify the study information or how the page is used.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab in Endometrial Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Endometrial Cancer Clinical Trial page.